Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.

Hiramatsu A, Aikata H, Uchikawa S, Ohya K, Kodama K, Nishida Y, Daijo K, Osawa M, Teraoka Y, Honda F, Inagaki Y, Morio K, Morio R, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Imamura M, Tanaka J, Chayama K.

Hepatol Commun. 2019 Jan 22;3(3):348-355. doi: 10.1002/hep4.1309. eCollection 2019 Mar.

2.

L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis.

Ohara M, Ogawa K, Suda G, Kimura M, Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ohnishi S, Sakamoto N.

Hepatol Commun. 2018 Aug 6;2(8):906-918. doi: 10.1002/hep4.1207. eCollection 2018 Aug.

3.

Sarcopenia impairs prognosis of patients with liver cirrhosis.

Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H.

Nutrition. 2015 Jan;31(1):193-9. doi: 10.1016/j.nut.2014.07.005. Epub 2014 Jul 30.

PMID:
25441595
4.

Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients.

Shiraki M, Shimizu M, Moriwaki H, Okita K, Koike K.

Hepatol Res. 2017 Mar;47(4):321-327. doi: 10.1111/hepr.12750. Epub 2016 Aug 2.

PMID:
27254133
5.

Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy.

Fukushima H, Nakanishi Y, Kataoka M, Tobisu KI, Koga F.

Clin Genitourin Cancer. 2017 Apr;15(2):e229-e238. doi: 10.1016/j.clgc.2016.08.004. Epub 2016 Aug 10.

PMID:
27601279
6.

Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.

Namba M, Hiramatsu A, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Tsuge M, Imamura M, Chayama K.

J Gastroenterol. 2019 Sep 4. doi: 10.1007/s00535-019-01623-4. [Epub ahead of print]

PMID:
31485782
8.

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.

Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S.

BMC Cancer. 2018 Jul 24;18(1):756. doi: 10.1186/s12885-018-4673-2.

9.

Muscle wasting is associated with mortality in patients with cirrhosis.

Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB.

Clin Gastroenterol Hepatol. 2012 Feb;10(2):166-73, 173.e1. doi: 10.1016/j.cgh.2011.08.028. Epub 2011 Sep 3.

PMID:
21893129
10.

Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.

Iwasa M, Sugimoto R, Ishihara T, Sekoguchi-Fujikawa N, Yoshikawa K, Mifuji-Moroka R, Tanaka H, Kobayashi Y, Hasegawa H, Takei Y.

J Nutr Sci Vitaminol (Tokyo). 2015;61(6):433-40. doi: 10.3177/jnsv.61.433.

11.

A Model to Identify Sarcopenia in Patients With Cirrhosis.

Tandon P, Low G, Mourtzakis M, Zenith L, Myers RP, Abraldes JG, Shaheen AA, Qamar H, Mansoor N, Carbonneau M, Ismond K, Mann S, Alaboudy A, Ma M.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1473-1480.e3. doi: 10.1016/j.cgh.2016.04.040. Epub 2016 May 14.

PMID:
27189915
12.

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.

Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, Beaumont C, Esfandiari N, Myers RP.

Clin Transl Gastroenterol. 2015 Jul 16;6:e102. doi: 10.1038/ctg.2015.31.

13.

Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis.

Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M.

Hepatol Res. 2016 Jul;46(8):743-51. doi: 10.1111/hepr.12616. Epub 2016 Jan 28.

PMID:
26579878
14.

Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis.

Hanai T, Shiraki M, Miwa T, Watanabe S, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M.

Hepatol Res. 2019 Jan;49(1):82-95. doi: 10.1111/hepr.13244. Epub 2018 Sep 25.

PMID:
30156741
15.

Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.

Montano-Loza AJ, Meza-Junco J, Baracos VE, Prado CM, Ma M, Meeberg G, Beaumont C, Tandon P, Esfandiari N, Sawyer MB, Kneteman N.

Liver Transpl. 2014 Jun;20(6):640-8. doi: 10.1002/lt.23863. Epub 2014 Mar 26.

16.

Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.

Imai K, Takai K, Watanabe S, Hanai T, Suetsugu A, Shiraki M, Shimizu M.

Nutrients. 2017 Sep 22;9(10). pii: E1054. doi: 10.3390/nu9101054.

17.

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

Oncol Lett. 2017 Aug;14(2):1637-1647. doi: 10.3892/ol.2017.6287. Epub 2017 May 31.

18.

Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.

Fukushima H, Kataoka M, Nakanishi Y, Sakamoto K, Takemura K, Suzuki H, Ito M, Tobisu KI, Fujii Y, Koga F.

Urol Oncol. 2018 Apr;36(4):156.e9-156.e16. doi: 10.1016/j.urolonc.2017.09.016. Epub 2017 Oct 17.

PMID:
29051030
19.

Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.

Davuluri G, Krokowski D, Guan BJ, Kumar A, Thapaliya S, Singh D, Hatzoglou M, Dasarathy S.

J Hepatol. 2016 Nov;65(5):929-937. doi: 10.1016/j.jhep.2016.06.004. Epub 2016 Jun 16.

20.

Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.

Kumar A, Davuluri G, Silva RNE, Engelen MPKJ, Ten Have GAM, Prayson R, Deutz NEP, Dasarathy S.

Hepatology. 2017 Jun;65(6):2045-2058. doi: 10.1002/hep.29107. Epub 2017 Apr 28.

Supplemental Content

Support Center